Status:
UNKNOWN
End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)
Lead Sponsor:
Philipps University Marburg
Collaborating Sponsors:
AstraZeneca
Conditions:
Chronic Obstructive Pulmonary Disease
End-of-Life Fear
Eligibility:
All Genders
50-75 years
Brief Summary
The aim of the study is to develop an interview to ask patients with COPD about their fear of death and dying, their needs and wishes at the end-of-life. Afterwards, the patients receive a brief psych...
Detailed Description
Background: COPD-related mortality differs markedly from that of other chronic diseases. While the mortality rates for heart disease and stroke have fallen significantly, death rates caused by COPD h...
Eligibility Criteria
Inclusion
- 50 years or older
- COPD diagnosis III and IV by GOLD-criteria with or without an indication for long-term oxygen therapy (LTOT), non invasive ventilation (NIV) and/or lung transplantation (LTx)
- COPD diagnosis II by GOLD-criteria
- Patients with hip prosthesis
- Mental healthy people, who have no severe illness (such as heart disease or cancer) one year before
Exclusion
- Participation in other studies likely to influence the patient in terms of confounding effects
- Acute and severe exacerbations with hard symptoms over 4 days
- Patients need a increasing medication of steroids and/or antibiotics
- Non-compliance
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2010
Estimated Enrollment :
199 Patients enrolled
Trial Details
Trial ID
NCT00792974
Start Date
October 1 2008
End Date
July 1 2010
Last Update
February 5 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Clinical Psychology and Psychotherapy, Philipps University Marburg
Marburg, Germany, 35032
2
Klinikum Berchtesgadener Land, Schön Kliniken
Schönau am Königssee, Germany, 83471